Milestone Pharma director granted 77,000 stock options
Milestone Pharmaceuticals director Seth H. Z. Fischer received a grant of stock options covering 77,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Milestone Pharmaceuticals director Seth H. Z. Fischer received a grant of stock options covering 77,000 shares of common stock. The options have an exercise price of $1.22 per share and expire on June 10, 2036. They vest in twelve equal monthly installments starting July 10, 2026, or will be fully vested by the next annual stockholder meeting if he continues serving.
Insider Trade Summary
Grant/Award: 77,000 shares
Grant/Award
1 txn
Insider
Fischer Seth H. Z.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 77,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 77,000 options (Direct)
Holdings Before and After:
Stock Option (right to buy), 0 to 77,000 options (Direct)
Footnotes (1)
- F1. This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.
Key Figures
Options granted: 77,000 options
Exercise price: $1.22 per share
Expiration date: June 10, 2036
+2 more
5 metrics
Options granted
77,000 options
Stock Option (right to buy) grant on June 10, 2026
Exercise price
$1.22 per share
Conversion or exercise price for the options
Expiration date
June 10, 2036
Option term for the 77,000 options
Underlying shares
77,000 shares
Common stock underlying the option grant
Post-grant derivative holdings
77,000 options
Total stock options held directly after the transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 1.2200"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-10T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"This option will vest in twelve (12) equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of the stockholders financial
"fully vested on the date of next annual meeting of the stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Milestone Pharmaceuticals (MIST) director Seth H. Z. Fischer report on this Form 4?
Seth H. Z. Fischer reported receiving a grant of stock options for 77,000 shares of Milestone Pharmaceuticals common stock. These options are compensation-related and were awarded at an exercise price of $1.22 per share, with vesting tied to his continued service on the board.
What are the key terms of the Milestone Pharmaceuticals (MIST) option grant to Seth H. Z. Fischer?
The grant covers 77,000 stock options with an exercise price of $1.22 per share and an expiration date of June 10, 2036. The options relate to Milestone Pharmaceuticals common stock and represent a right to buy shares rather than an immediate stock purchase.
How do the 77,000 Milestone Pharmaceuticals (MIST) options granted to Seth H. Z. Fischer vest?
The 77,000 options vest in twelve equal monthly installments beginning July 10, 2026. They will in any case be fully vested by the date of the next annual stockholders’ meeting, provided Fischer continues to provide service through each applicable vesting date.
Is the Milestone Pharmaceuticals (MIST) Form 4 transaction an open-market buy or sell?
The Form 4 reflects a compensation-related grant of stock options, not an open-market buy or sell transaction. The options were awarded at an exercise price of $1.22 per share and give Fischer the right to purchase Milestone Pharmaceuticals common stock in the future.
What is Seth H. Z. Fischer’s reported option position in Milestone Pharmaceuticals (MIST) after this grant?
After this grant, Fischer is reported to hold 77,000 stock options directly. Each option is exercisable into one share of Milestone Pharmaceuticals common stock at $1.22 per share, with an expiration date of June 10, 2036, subject to the stated vesting schedule.
AI-generated analysis. How Rhea-AI works. Not financial advice.
